Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' CHOLLET P' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 82 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Auzary, C; Du Boutin, LTH; Wechsler, B; Chollet, P; Piette, JC
      Disseminated nocardiosis presenting as a flare of Behcet's disease

      RHEUMATOLOGY
    2. Misset, JL; Vennin, P; Chollet, P; Pouillart, P; Laplaige, P; Frobert, JL; Castera, D; Fabro, M; Langlois, D; Cortesi, E; Lucas, V; Gamelin, E; Laadem, A; Otero, J
      Multicenter phase II-III study of oxaliplatin plus cyclophosphamide vs. cisplatin plus cyclophosphamide in chemonaive advanced ovarian cancer patients

      ANNALS OF ONCOLOGY
    3. Adenis, A; Bonneterre, J; Bonneterre, ME; Pion, JM; Vanlemmens, L; Gladieff, L; de Lafontan, B; Martel, P; Mihura, J; Roche, H; Gedouin, D; Kerbrat, P; Lesimple, T; Bremond, A; Devaux, Y; Delecroix, V; Fumoleau, P; Maugard-Louboutin, C; Namer, M; Goudier, MJ; Morice, F; Montcuquet, P; Schraub, S; Coudert, B; Fargeot, P; de Gislain, C; Mayer, F; Bastit, P; Chevallier, B; Grandgirard, A; Monnier, A; Sun, X; Clavere, P; Ollivier, JP; Rhein, B; Roullet, B; Datchary, J; Audhuy, B; Barats, JC; Kohser, F; Dides, S; Ramos, R; Cattan, A; Eymard, JC; Pourny, C; Weber, B; de Laroche, G; Pichon, A; Seffert, P; Hayat, M; Zambon, E; Chollet, P; Van Praagh, I
      Benefit of a high-dose epirubicin regimen in adjuvant chemotherapy for node-positive breast cancer patients with poor prognostic factors: 5-year follow-up results of French adjuvant study group 05 randomized trial

      JOURNAL OF CLINICAL ONCOLOGY
    4. Khayat, D; Chollet, P; Antoine, EC; Monfardini, S; Ambrosini, G; Benhammouda, A; Mazen, MF; Sorio, R; Borg-Olivier, O; Ramazeilles, C; Azli, N
      Phase II study of sequential administration of docetaxel followed by doxorubicin and cyclophosphamide as first-line chemotherapy in metastatic breastcancer

      JOURNAL OF CLINICAL ONCOLOGY
    5. Marchenay, C; Cellarier, E; Levi, F; Rolhion, C; Kwiatkowski, F; Claustrat, B; Madelmont, JC; Chollet, P
      Circadian variation in O-6-alkylguanine-DNA alkyltransferase activity in circulating blood mononuclear cells of healthy human subjects

      INTERNATIONAL JOURNAL OF CANCER
    6. Cure, H; Bay, JO; Plagne, R; Chollet, P; Dauplat, J
      High-dose chemotherapy in advanced epithelial ovarian cancer

      BULLETIN DU CANCER
    7. Bastit, P; Chevallier, B; Chevreau, C; Mihura, J; Roche, H; Namer, M; Gedouin, D; Kerbrat, P; Lesimple, T; Coudert, B; Fargeot, P; de Gislain, C; Mayer, F; Luporsi, E; Rios, M; Weber, B; Bremond, A; Devaux, Y; Monteuquet, P; Schraub, S; Hayat, M; Zambon, E; Grandgirard, A; Monnier, A; Sun, X; Clavere, P; Ollivier, JP; Rhein, B; Roullet, B; Chollet, P; Van Praagh, I; Cattan, A; Eymard, JC; Pourny, C; Facchini, T; Walter, S; Dides, S; Ramos, R; Guiochet, N; Seffert, P; Perpoint, X; Sztermer, JF; Cretin, J; Goudier, MJ; Morice, F; Delecroix, V; Fumoleau, P
      Epirubicin-based chemotherapy in metastatic breast cancer patients: Role of dose-intensity and duration of treatment

      JOURNAL OF CLINICAL ONCOLOGY
    8. Giacchetti, S; Perpoint, B; Zidani, R; Le Bail, N; Faggiuolo, R; Focan, C; Chollet, P; Llory, JF; Letourneau, Y; Coudert, B; Bertheaut-Cvitkovic, F; Larregain-Fournier, D; Le Rol, A; Walter, S; Adam, R; Misset, JL; Levi, F
      Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer

      JOURNAL OF CLINICAL ONCOLOGY
    9. Charrier, S; Chollet, P; Bay, JO; Cure, H; Kwiatkowski, F; Portefaix, G; Communal, Y; Betail, G; Plagne, R; Chassagne, J
      Hematological recovery and peripheral blood progenitor cell mobilization after induction chemotherapy and GM-CSF plus G-CSF in breast cancer

      BONE MARROW TRANSPLANTATION
    10. Cure, H; Chevalier, V; Pezet, D; Bousquet, J; Focan, C; Levi, F; Garufi, C; Chipponi, J; Chollet, P
      Phase II trial of chronomodulated infusion of 5-fluorouracil and folinic acid in metastatic colorectal cancer

      ANTICANCER RESEARCH
    11. Roche, H; Cure, H; Adenis, A; Fargeot, P; Terret, C; Lentz, MA; Madelmont, JC; Fumoleau, P; Hanauske, A; Chollet, P
      Phase II trial of cystemustine, a new nitrosourea, as treatment of high-grade brain tumors in adults

      JOURNAL OF NEURO-ONCOLOGY
    12. Cure, H; Dauplat, J; Chollet, P
      First line chemotherapy for advanced ovarian cancer in 2000: standards andquestions

      BULLETIN DU CANCER
    13. Coll, JL; Chollet, P; Brambilla, E; Desplanques, D; Behr, JP; Favrot, M
      In vivo delivery to tumors of DNA complexed with linear polyethylenimine

      HUMAN GENE THERAPY
    14. Cure, H; Souteyrand, P; Ouabdesselam, R; Roche, H; Ravaud, A; D'incan, M; Viens, P; Fargeot, P; Lentz, MA; Fumoleau, P; Hanauske, A; Chollet, P
      Results of a phase II trial with cystemustine at 90 mg/m(2) as a first- orsecond-line treatment in advanced malignant melanoma: a trial of the EORTCClinical Studies Group

      MELANOMA RESEARCH
    15. Bonneterre, J; Spielman, M; Guastalla, JP; Marty, M; Viens, P; Chollet, P; Roche, H; Fumoleau, P; Mauriac, L; Bourgeois, H; Namer, M; Bergerat, JP; Misset, JL; Trandafir, L; Mahjoubi, M
      Efficacy and safety of docetaxel (Taxotere (TM)) in heavily pretreated advanced breast cancer patients: the French compassionate use programme experience

      EUROPEAN JOURNAL OF CANCER
    16. Schoffski, P; Chollet, P; Ganser, A; Wiese, KH; Rambusch, E; de Vries, MJ; Hanauske, A
      Complete response of a gastric primary after a short but toxic course of 'S-1'

      ANNALS OF ONCOLOGY
    17. Le Bouedec, G; Charrier, S; Cure, H; de Latour, MP; Ferriere, JP; Chollet, P; Dauplat, J
      Role for surgery after complete clinical response to neoadjuvant chemotherapy for breast cancer

      PRESSE MEDICALE
    18. Garufi, C; Dogliotti, L; Terzoli, E; Focan, C; Smaaland, R; Chollet, P; Perpoint, B; Levi, F
      Letter to the Editor

      TUMORI
    19. Rolhion, C; Penault-Llorca, F; Kemeny, JL; Kwiatkowski, F; Lemaire, JJ; Chollet, P; Finat-Duclos, F; Verrelle, P
      O-6-methylguanine-DNA methyltransferase gene (MGMT) expression in human glioblastomas in relation to patient characteristics and p53 accumulation

      INTERNATIONAL JOURNAL OF CANCER
    20. Levi, F; Zidani, R; Brienza, S; Dogliotti, L; Perpoint, B; Rotarski, M; Letourneau, Y; Llory, JF; Chollet, P; Le Rol, A; Focan, C
      A multicenter evaluation of intensified, ambulatory, chronomodulated chemotherapy with oxaliplatin, 5-fluorouracil, and leucovorin as initial treatment of patients with metastatic colorectal carcinoma

      CANCER
    21. CURE H; KRAKOWSKI I; ADENIS A; TUBIANA N; KERBRAT P; ROCHE H; CHEVALLIER B; LENTZ MA; FUMOLEAU P; CHOLLET P
      RESULTS OF A PHASE-II TRIAL WITH 2ND-LINE CYSTEMUSTINE AT 60 MG M(2) IN ADVANCED SOFT-TISSUE SARCOMA - A TRIAL OF THE EORTC EARLY CLINICAL-STUDIES GROUP/

      European journal of cancer
    22. GACHON F; CHARRIER S; KWIATKOWSKI F; BESSE G; CURE H; CHASSAGNE J; FERRIERE JP; PENAULTLLORCA F; DAUPLAT J; CHOLLET P
      EXPRESSION OF CYTOSOLIC THYMIDINE KINASE IN THE PROLIFERATIVE BREAST-CARCINOMA AFTER PRIMARY CHEMOTHERAPY - THERAPEUTIC INDICATION

      European journal of cancer
    23. DIPALMA M; DELALOGE S; GUERIN S; FARGEOT P; CONROY T; CHOLLET P; MISSET JL
      ADJUVANT CHEMOTHERAPY PLUS ALTERNATED HORMONAL-THERAPY (AVCF-TM) FOR HR-CANCER - 13-YEAR RESULTS OF A RANDOMIZED PHASE-III TRIAL( N+ BREAST)

      European journal of cancer
    24. ANTOINE EC; CHOLLET P; MONFARDINI S; SORIO R; AMBROSINI G; BENHAMMOUDA A; MAZEN MF; RAMAZEILLES C; AZLI N; KHAYAT D
      SEQUENTIAL ADMINISTRATION OF DOCETAXEL (D) (TAXOTERE(TM)) FOLLOWED BYAC IN FIRST LINE METASTATIC BREAST-CANCER (MBC) PATIENTS (PTS) - FINAL RESULTS

      Annals of oncology
    25. CURE H; VANPRAAGH I; CHARRIER S; KWIATKOWSKI F; FERRIERE JP; CHOLLET P
      PHASE-I OF DOXORUBICIN AND IFOSFAMIDE ASSOCIATION FOR FIRST LINE ADVANCED BREAST-CANCER (ABC)

      Annals of oncology
    26. FERRIERE JP; ASSIER I; CURE H; CHARRIER S; KWIATKOWSKI F; ACHARD JL; DAUPLAT J; CHOLLET P
      PRIMARY CHEMOTHERAPY IN BREAST-CANCER - CORRELATION BETWEEN TUMOR RESPONSE AND PATIENT OUTCOME

      American journal of clinical oncology
    27. CHARRIER S; CHASSAGNE J; CURE H; BAY JO; COMMUNAL Y; PORTEFAIX G; FERRIERE JP; BETAIL G; PLAGNE R; CHOLLET P
      MOBILIZATION OF PERIPHERAL-BLOOD PROGENITOR CELLS AFTER INDUCTION CHEMOTHERAPY RUBICIN-VINORELBINE-CYCLOPHOSPHAMIDE-FLUOROURACIL) AND GRANULOCYTE-COLONY-STIMULATING FACTOR IN BREAST-CANCER

      Bone marrow transplantation
    28. BAY JO; FOUASSIER M; BEAL D; ALCARAZ L; CURE H; CHOLLET P; PLAGNE R; TRAVADE P
      AUTOIMMUNE THROMBOCYTOPENIA AFTER 6 CYCLES OF FLUDARABINE PHOSPHATE IN A PATIENT WITH CHRONIC LYMPHOTIC LEUKEMIA

      HEMATOLOGY AND CELL THERAPY
    29. SOULIE P; BENSMAINE A; GARRINO C; CHOLLET P; BRAIN E; FERERES M; JASMIN C; MUSSET M; MISSET JL; CVITKOVIC E
      OXALIPLATIN CISPLATIN (L-OHP/CDDP) COMBINATION IN HEAVILY PRETREATED OVARIAN-CANCER/

      European journal of cancer
    30. CHOLLET P; CHARRIER S; BRAIN E; CURE H; VANPRAAGH I; FEILLEL V; DELATOUR M; DAUPLAT J; MISSET JL; FERRIERE JP
      CLINICAL AND PATHOLOGICAL RESPONSE TO PRIMARY CHEMOTHERAPY IN OPERABLE BREAST-CANCER

      European journal of cancer
    31. CHARRIER S; FERRIERE JP; KWIATKOWSKI F; CURE H; VANPRAAGH I; FEILLEL V; ASSIER I; BAY JO; DAUPLAT J; CHOLLET P
      OPTIMAL DURATION OF NEOADJUVANT CHEMOTHERAPY - 3 OR 4 VERSUS 6 CYCLESIN 3 SCHEMES FOR OPERABLE BREAST-CANCER

      European journal of cancer
    32. LACASSAGNE L; DIDIER A; MURRISESPIN M; CHARLET JP; CHOLLET P; LEOPHONTEDOMAIRON ML; TIBERGE M; PESSEY JJ; LEOPHONTE P
      PLACE OF NOCTURNAL OXYMETRY IN THE EARLY DETECTION OF THE SLEEP-APNEASYNDROME IN RESPIRATORY MEDICINE - A STUDY OF 329 PATIENTS

      Revue des maladies respiratoires
    33. LEGROS M; DAUPLAT J; FLEURY J; CURE H; SUZANNE F; CHASSAGNE J; BAY JO; SOL C; CANIS M; CONDAT P; CHOUFI B; TAVERNIER F; GLENAT C; CHOLLET P; PLAGNE R
      HIGH-DOSE CHEMOTHERAPY WITH HEMATOPOIETIC RESCUE IN PATIENTS WITH STAGE-III TO STAGE-IV OVARIAN-CANCER - LONG-TERM RESULTS

      Journal of clinical oncology
    34. MALECAZE F; SIMORRE V; CHOLLET P; TACK JL; MURAINE M; LEGUELLEC D; VITA N; ARNE JL; DARBON JM
      INTERLEUKIN-6 IN TEAR FLUID AFTER PHOTOREFRACTIVE KERATECTOMY AND ITSEFFECTS ON KERATOCYTES IN CULTURE

      Cornea
    35. FERRIERE JP; CHARRIER S; CURE H; KWIATKOWSKI F; COURTADON M; BELEMBAOGO E; DELATOUR M; ACHARD JL; DAUPLAT J; CHOLLET P
      ADJUVANT CHEMOTHERAPY WITH DOXORUBICIN-CONTAINING REGIMEN FOR 326 STAGE-II BREAST CANCERS - 15-YEAR RESULTS

      American journal of clinical oncology
    36. LEGROS M; FLEURY J; BAY JO; CHOUFI B; BASILE M; CONDAT P; GLENAT C; COMMUNAL Y; TAVERNIER F; BONS JM; CHOLLET P; PLAGNE R; CHASSAGNE J
      RHGM-CSF VS PLACEBO FOLLOWING RHGM-CSF-MOBILIZED PBPC TRANSPLANTATION- A PHASE-III DOUBLE-BLIND RANDOMIZED TRIAL

      Bone marrow transplantation
    37. CURE H; CHARRIER S; FERRIERE JP; VANPRAAGH I; ASSIER I; FEILLEL V; DELATOUR M; BAY JO; ACHARD JL; DAUPLAT J; CHOLLET P
      RESULTS OF 3 NEOADJUVANT CHEMOTHERAPY REG IMEN FOR OPERABLE BREAST-CANCER

      Bulletin du cancer
    38. FLEURY J; LEGROS M; COLOMBAT P; CURE H; TRAVADE P; TORTOCHAUX J; DIONET C; CHOLLET P; LINASSIER C; LAMAGNERE JP; BLAISE D; VIENS P; MARANINCHI D; PLAGNE R
      HIGH-DOSE THERAPY AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN FIRSTCOMPLETE OR PARTIAL REMISSION FOR POOR-PROGNOSIS HODGKINS-DISEASE

      Leukemia & lymphoma
    39. UROSEVIC V; CHOLLET P; ADENIS A; CHAUVERGNE J; FARGEOT P; ROCHE H; KERBRAT P; LENTZ MA; FUMOLEAU P; CHEVALLIER B
      RESULTS OF A PHASE-II TRIAL WITH CYSTEMUSTINE IN ADVANCED MALIGNANT-MELANOMA - A TRIAL OF THE EORTC CLINICAL SCREENING GROUP

      European journal of cancer
    40. MARTINEAUPIVOTEAU N; CUSSACBUCHDAHL C; CHOLLET P; ROLHION C; DEBITON E; RAPP M; KWIATKOWSKI F; MADELMONT JC; LEVI F
      CIRCADIAN VARIATION IN O-6-METHYLGUANINE-DNA METHYLTRANSFERASE ACTIVITY IN MOUSE-LIVER

      Anti-cancer drugs
    41. CHOLLET P; BENSMAINE MA; BRIENZA S; DELOCHE C; CURE H; CAILLET H; CVITKOVIC E
      SINGLE-AGENT ACTIVITY OF OXALIPLATIN IN HEAVILY PRETREATED ADVANCED EPITHELIAL OVARIAN-CANCER

      Annals of oncology
    42. CHOLLET P; MALECAZE F; TOAN PLL; LAMCHE H; ARNE JL
      ANNEXIN V-COATED INTRAOCULAR LENSES

      Journal of cataract and refractive surgery
    43. MISSET JL; DIPALMA M; DELGADO M; PLAGNE R; CHOLLET P; FUMOLEAU P; LEMEVEL B; BELPOMME D; GUERRIN J; FARGEOT P; METZ R; ITHZAKI M; HILL C; MATHE G
      ADJUVANT TREATMENT OF NODE-POSITIVE BREAST-CANCER WITH CYCLOPHOSPHAMIDE, DOXORUBICIN, FLUOROURACIL AND VINCRISTINE VERSUS CYCLOPHOSPHAMIDE,METHOTREXATE, AND FLUOROURACIL - FINAL REPORT AFTER A 16-YEAR MEDIAN FOLLOW-UP DURATION

      Journal of clinical oncology
    44. BACIN F; UROSEVIC V; CURE H; MADELMONT JC; VEYRE A; CHOLLET P
      CHEMOTHERAPY OF METASTATIC UVEAL MELANOMA USING CYSTEMUSTINE

      Vision research
    45. MARTINEAUPIVOTEAU N; LEVI F; ROLHION C; KWIATKOWSKI F; LEMAIGRE G; FILIPSKI E; CHOLLET P
      CIRCADIAN-RHYTHM IN TOXIC EFFECTS OF CYSTEMUSTINE IN MICE - RELEVANCEFOR CHRONOMODULATED DELIVERY

      International journal of cancer
    46. PORTEFAIX G; COMMUNAL Y; FLEURY J; CURE H; CHOUFI B; FOUASSIER M; BONS JM; GLENAT C; CHOLLET P; CHASSAGNE J; PLAGNE R; LEGROS M
      INTEREST OF HIGH FLUORESCENCE RETICULOCYTES (HFR)EVALUATION IN OPTIMAL TIME DETERMINATION OF PERIPHERAL-BLOOD PROGENITOR-CELL (PBPC) HAVESTING

      Blood
    47. CAPPELAERE P; LENTZ MA; DEGARDIN M; CHAUVERGNE J; MAYER F; CHOLLET P; CHEVALLIER B
      PHASE-II STUDY OF CYSTEMUSTINE IN ADVANCED HEAD AND NECK-CANCER - A TRIAL OF THE EORTC CLINICAL SCREENING GROUP

      European journal of cancer. Part B, Oral oncology
    48. CHAUVERGNE J; KERBRAT P; ADENIS A; CHOLLET P; FARGEOT P; PUJADELAURAINE E; DIERAS V; MADELMONT JC; LENTZ MA; TOULOUSE C; CHEVALLIER B
      PHASE-II STUDY OF CYSTEMUSTINE IN ADVANCED RENAL-CANCER

      European journal of cancer
    49. VANPRAGGH I; FERRIERE JP; CURE H; FEILLEL V; LEBOUEDEC G; DELATOUR M; ROLHION C; CHARRIER S; ASSIER I; MISSET JL; DAUPLAT J; CHOLLET P
      COMPARISON OF 3 NEOADJUVANT CHEMOTHERAPY REGIMENS FOR OPERABLE BREAST-CANCER

      European journal of cancer
    50. PERETZ T; SULKES A; CHOLLET P; GELMON K; PARIDAENS R; GORBONUVA V; CATIMEL G; KUHNLE H; HUININK WTB; KHAYAT D; DITTRICH C; KLAASSEN U; BERGH J; WILKING N; NABHOLTZ JM; CALABRESI F; TUBIANAHULIN M; CHAZARD M; GALLANT G; DIERGARTEN K; WESTBERG R; BOGAERT J; RENARD J; WEIL C
      A MULTICENTER, RANDOMIZED STUDY OF 2 SCHEDULES OF PACLITAXEL (PTX) INPATIENTS WITH ADVANCED BREAST-CANCER (ABC)

      European journal of cancer
    51. BONNETERRE J; TUBIANAHULIN M; CHOLLET P; CHEVALLIER B; FUMOLEAU P; KERBRAT P; VIE B; KHAYAT D; TUBIANA N; LEJEUNE C; LEGRAND A; SOARES JA; PELLAECOSSET B
      TAXOL(R) (PACLITAXEL) 225 MG M(2) BY 3-HOUR INFUSION WITHOUT G-CSF ASA FIRST LINE THERAPY IN PATIENTS WITH METASTATIC BREAST-CANCER (MBC)/

      European journal of cancer
    52. TERRET C; GONCALVES E; DACOSTA L; UROSEVIC V; CHOLLET P; MADELMONT J; ARMAND JP
      PHASE-I TRIAL OF A NEW NITROSUREA INA WEEKLY SCHEDULE

      European journal of cancer
    53. CHEVALLIER B; CHOLLET P; MERROUCHE Y; ROCHE H; FUMOLEAU P; KERBRAT P; GENOT Y; FARGEOT P; OLIVIER JP; FIZAMES C; CLAVEL M; YVER A; CHABERNAUD VC
      LENOGRASTIM PREVENTS MORBIDITY FROM INTENSIVE INDUCTION CHEMOTHERAPY IN THE TREATMENT OF INFLAMMATORY BREAST-CANCER

      Journal of clinical oncology
    54. LEGROS M; FLEURY J; CURE H; CONDAT P; LENAT A; SUBTIL E; SANDERSON D; COMMUNAL Y; BASILE M; TAVERNIER F; CHOUFFI B; CHOLLET P; PLAGNE R; CHASSAGNE J
      NEW METHOD FAIR STEM-CELL QUANTIFICATION - APPLICATIONS TO THE MANAGEMENT OF PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION

      Bone marrow transplantation
    55. PERRONBUSCAIL A; LESUEUR L; CHOLLET P; ARNE JL
      ELECTRICAL BURNS OF THE CORNEA - AN ANATO MOCLINICAL CASE-REPORT

      Journal francais d'ophtalmologie
    56. GUERRIN M; MOUKADIRI H; CHOLLET P; MORO F; DUTT K; MALECAZE F; PLOUET J
      VASCULOTROPIN VASCULAR ENDOTHELIAL GROWTH-FACTOR IS AN AUTOCRINE GROWTH-FACTOR FOR HUMAN RETINAL-PIGMENT EPITHELIAL-CELLS CULTURED IN-VITRO

      Journal of cellular physiology
    57. FLEURY J; LEGROS M; CURE H; TORTOCHAUX J; CONDAT P; DIONET C; TRAVADE P; BELEMBAOGO E; TAVERNIER F; KWIATKOWSKI F; CHOLLET P; PLAGNE R
      THE HEMATOPOIETIC STEM-CELL TRANSPLANTATION IN HODGKINS-DISEASE - QUESTIONS AND CONTROVERSIES

      Leukemia & lymphoma
    58. CHOLLET P; EYREMANDI R; LESUEUR L; ARNE JL
      ERDHEIM-CHESTER-DISEASE - A RARE ETIOLOGY OF RETRO-OCULAR TUMOR

      Journal francais d'ophtalmologie
    59. SIMORREPINATEL V; GUERRIN M; CHOLLET P; PENARY M; CLAMENS S; MALECAZE F; PLOUET J
      VASCULOTROPIN VEGF STIMULATES RETINAL CAPILLARY ENDOTHELIAL-CELLS THROUGH AN AUTOCRINE PATHWAY

      Investigative ophthalmology & visual science
    60. MURAINE M; PENARY M; CHOLLET P; SIMORRE V; PLOUET J; ARNE JL; MALECAZE F
      HUMAN KERATOCYTES BIND AND SYNTHESIZE VAS VEGF/

      Investigative ophthalmology & visual science
    61. MALECAZE F; TACK JL; CHOLLET P; SIMORRE V; LEGUELLEC D; VITA N; ARNE JL
      INTERLEUKIN-6 (IL-6) AND PHOTOREFRACTIVE KERATECTOMY (PRK)

      Investigative ophthalmology & visual science
    62. CHOLLET P; MALECAZE F; ARNE JL; LAMCHE H; LETOAN P; LESUEUR L; MAURERFOGY I
      EFFICACY OF ANNEXIN V-COATED INTRAOCULAR LENSES IN THE PREVENTION OF POSTOPERATIVE INFLAMMATION

      Investigative ophthalmology & visual science
    63. GODENECHE D; LABARRE P; CUSSAC C; MADELMONT JC; DUPUY JM; FONTANON C; TISSERANT A; CHOLLET P; BAUDRY JP; VEYRE A
      PHARMACOKINETICS OF 2 NEW 2-CHLOROETHYLNITROSOUREAS IN CANCER-PATIENTS SUBMITTED TO PHASE-II CLINICAL-TRIALS

      Drug investigation
    64. CUSSAC C; MOUNETOU E; RAPP M; MADELMONT JC; MAURIZIS JC; LABARRE P; CHOLLET P; CHABARD JL; GODENECHE D; BAUDRY JP; VEYRE A
      DISPOSITION AND METABOLISM OF O-6-ALKYLGUANINE-DNA ALKYLTRANSFERASE INHIBITOR IN NUDE-MICE BEARING HUMAN-MELANOMA

      Drug metabolism and disposition
    65. CARRE P; ROUSSEAU H; LOMBART L; DIDIER A; DAHAN M; FOURNIAL G; LEOPHONTE P; MURRIS DM; CHOLLET P; BERJAUD J; ROUG P; MEUSBURGER B; JOFFRE F; BESOMBES P; PUELMRINI C; PECOUL J; DURAND D; LLOVERAS JJ; ROSTAING L
      BALLOON DILATATION AND SELF-EXPANDING METAL WALLSTENT INSERTION - FORMANAGEMENT OF BRONCHOSTENOSIS FOLLOWING LUNG TRANSPLANTATION

      Chest
    66. FLEURY J; TORTOCHAUX J; LEGROS M; CURE H; KWIATKOWSKI F; FERRIERE JP; TRAVADE P; DIONET C; GAILLARD G; CHASSAGNE J; BIGNON YJ; VANPRAAGH I; BELEMBAOGO E; CHOLLET P; PLAGNE R
      PRONOSTIC VALUE OF BETA-2-MICROGLOBULIN I N YOUNG-ADULTS WITH HODGKINS-DISEASE

      Bulletin du cancer
    67. LEGROS M; FLEURY J; CURE H; BASILE M; CHOUFI B; COMMUNAL Y; CHOLLET P; TRAVADE P; CONDAT P; PLAGNE R; CHASSAGNE J
      R-HU GM-CSF AFTER HIGH-DOSE CHEMOTHERAPY (HDC) AND PERIPHERAL-BLOOD PROGENITOR-CELL (PBPC) RESCUE - AN UNICENTER RANDOMIZED STUDY OF 50 PATIENTS

      Blood
    68. MALECAZE F; CLAMENS S; SIMORREPINATEL V; MATHIS A; CHOLLET P; FAVARD C; BAYARD F; PLOUET J
      DETECTION OF VASCULAR ENDOTHELIAL GROWTH-FACTOR MESSENGER-RNA AND VASCULAR ENDOTHELIAL GROWTH FACTOR-LIKE ACTIVITY IN PROLIFERATIVE DIABETIC-RETINOPATHY

      Archives of ophthalmology
    69. LEVI FA; ZIDANI R; VANNETZEL JM; PERPOINT B; FOCAN C; FAGGIUOLO R; CHOLLET P; GARUFI C; ITZHAKI M; DOGLIOTTI L; IACOBELLI S; ADAM R; KUNSTLINGER F; GASTIABURU J; BISMUTH H; JASMIN C; MISSET JL
      CHRONOMODULATED VERSUS FIXED-INFUSION-RATE DELIVERY OF AMBULATORY CHEMOTHERAPY WITH OXALIPLATIN, FLUOROURACIL, AND FOLINIC ACID (LEUCOVORIN) IN PATIENTS WITH COLORECTAL-CANCER METASTASES - A RANDOMIZED MULTIINSTITUTIONAL TRIAL

      Journal of the National Cancer Institute
    70. LEVI FA; ZIDANI R; VANNETZEL JM; PERPOINT B; FOCAN C; FAGGIUOLO R; CHOLLET P; GARUFI C; ITZHAKI M; DOGLIOTTI L; IACOBELLI S; ADAM R; KUNSTLINGER F; GASTIABURU J; BISMUTH H; JASMIN C; MISSET JL
      CHRONOMODULATED VERSUS FIXED-INFUSION-RATE DELIVERY OF AMBULATORY CHEMOTHERAPY WITH OXALIPLATIN, FLUOROURACIL, AND FOLINIC ACID (LEUCOVORIN) IN PATIENTS WITH COLORECTAL-CANCER METASTASES - A RANDOMIZED MULTIINSTITUTIONAL TRIAL

      Journal of the National Cancer Institute
    71. ATTIASOBOL J; FERRIERE JP; CURE H; KWIATKOWSKI F; ACHARD JL; VERRELLE P; FEILLEL V; DELATOUR M; LAFAYE C; DELOCHE C; DAUPLAT J; DOLY A; ROZAN R; CHOLLET P
      TREATMENT RESULTS, SURVIVAL AND PROGNOSTIC FACTORS IN 109 INFLAMMATORY BREAST CANCERS - UNIVARIATE AND MULTIVARIATE-ANALYSIS

      European journal of cancer
    72. KERBRAT P; ADENIS A; REBATTU P; ROCHE H; CHEVALLIER B; CHOLLET P; KRAKOWSKI I; LENTZ MA; FUMOLEAU P
      PHASE-II STUDY OF CYSTEMUSTINE IN METASTATIC COLORECTAL-CARCINOMA - ATRIAL OF THE EORTC CLINICAL SCREENING GROUP

      European journal of cancer
    73. FUMOLEAU P; DELGADO FM; DELOZIER T; MONNIER A; DELGADO MAG; KERBRAT P; GARCIAGIRALT E; KEILING R; NAMER M; CLOSON MT; GOUDIER MJ; CHOLLET P; LECOURT L; MONTCUQUET P
      PHASE-II TRIAL OF WEEKLY INTRAVENOUS VINORELBINE IN 1ST-LINE ADVANCEDBREAST-CANCER CHEMOTHERAPY

      Journal of clinical oncology
    74. CHEVALLIER B; ROCHE H; OLIVIER JP; CHOLLET P; HURTELOUP P
      INFLAMMATORY BREAST-CANCER - PILOT-STUDY OF INTENSIVE INDUCTION CHEMOTHERAPY (FEC-HD) RESULTS IN A HIGH HISTOLOGIC RESPONSE RATE

      American journal of clinical oncology
    75. BEGASSE F; CHAMONTIN B; TIBERGE M; CHOLLET P; AMAR J; DIDIER A; LEOPHONTE P; ARBUS L; SALVADOR M
      NYCTHEMERAL BLOOD-PRESSURE VARIABILITY IN OBSTRUCTIVE SLEEP-APNEA SYNDROME - RELATIONSHIP TO LEFT-VENTRICULAR HYPERTROPHY AND METABOLIC DISORDERS

      Journal of hypertension
    76. CURE H; PEZET D; FLEURY J; SLIM K; CHOLLET P; PLAGNE R; CHIPPONI J
      IS ESOPHAGEAL CANCER CHEMOSENSITIVE - SIG NIFICANCE OF A COMBINATION OF 2 PLATINUM SALTS (CARBOPLATIN AND CISPLATIN) AND FLUOROURACIL

      La Revue de medecine interne
    77. BERNARD D; BIGNON YJ; LAVENUE F; PAUCHARD J; DEMEOCQ F; TRAVADE P; PHILIPPE P; LEGROS M; CURE H; CHASSAGNE J; CHOLLET P; PLAGNE R
      LINEAGE PROMISCUITY IN LEUKEMIA STUDIES OF T-CELL RECEPTOR AND IMMUNOGLOBULIN GENES

      Leukemia research
    78. CHOLLET P; MALECAZE F; GOUZI L; ARNE JL; PLOUET J
      ENDOTHELIN-1 IS A GROWTH-FACTOR FOR CORNEAL ENDOTHELIUM

      Experimental Eye Research
    79. LEGROS M; FLEURY J; BASILE M; CURE H; TAVERNIER F; CONDAT P; CHOLLET P; PLAGNE R; CHASSAGNE J
      PERIPHERAL-BLOOD PROGENITOR-CELL (PBPC) MOBILIZATION AFTER HIGH-DOSE OF CYCLOPHOSPHAMIDE (CTX) PLUS ETOPOSIDE (VP16) AND RHU-GM-CSF (MOLGRAMOSTIM)

      Blood
    80. MALECAZE F; GOUZI L; ARNE JL; CHOLLET P; PLOUET J
      GROWTH-FACTOR ACTIVITY OF ENDOTHELINS ON CORNEAL ENDOTHELIAL-CELLS

      Investigative ophthalmology & visual science
    81. CHOLLET P; ARNE JL; VITA N; CAVROIS E; FERRARA P; MALECAZE F
      PRODUCTION OF INTERLEUKIN-6 AFTER RADIAL KERATOTOMIES

      Investigative ophthalmology & visual science
    82. PLOUET J; CHOLLET P; PAGOT V; CHAUVAUD D; KOROBELNIK JF; FAVARD C; MATHIS A; MALECAZE F
      VASCULOTROPIN VEGF LEVELS IN THE VITREOUS OF PATIENTS WITH PROLIFERATIVE DIABETIC-RETINOPATHY/

      Investigative ophthalmology & visual science


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 21/10/20 alle ore 19:18:52